Study reveals the Prospector calculator reduces antibiotic prescriptions in COPD exacerbations, improving outcomes and ...

Data support recommendations if patients are treated on an outpatient basis ... Conclusion. In the treatment of COPD exacerbations, systemic corticosteroids improve airflow limitations, decrease ...

Patients with acute COPD exacerbation should be treated with systemic corticosteroids, antibiotics and NPPV. Systemic corticosteroids reduce treatment failures in both in-hospital and outpatient ...

GlaxoSmithKline (GSK) has announced full results from the Salford Lung Study (SLS), a pioneering study of COPD treatment aimed ... rate of moderate or severe exacerbations by 8.4% compared to ...

Results Azithromycin treatment significantly reduced sputum ... double-blind study of the efficacy of azithromycin in the chronic, outpatient management of COPD with a primary outcome of time to first ...

There has been a steady rise since the early 1990s in the number of admissions to hospital for COPD. This is despite the fact that relatively few patients with an exacerbation are admitted, with most ...

Background Previous models of Hospital at Home (HAH) for COPD exacerbation (ECOPD ... 90% of patients across both arms stated they would prefer HAH treatment during future exacerbations of similar ...

Tezepelumab did not significantly decrease moderate or severe COPD exacerbations compared with placebo, the COURSE trial found.

Among patients with COPD who experienced an exacerbation, the risk for cardiovascular events was highest in the following 2 weeks and stayed elevated more than 1 year after, according to study results ...

Explore strategies for controlling COPD and improving health, with a focus on management and lifestyle changes.